loader
Please Wait
Applying Filters...
menu
    • menu

    Annual Sales of Ferric Carboxymaltose reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Minbiotech Ferric Carboxymaltose

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Ferric Carboxymaltose

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 10,449Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 7Injectafer

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Injectafer

    Ferric Carboxymaltose

    arrow
    FNCE 2024
    Not Confirmed

    Brand Name : Injectafer

    Japan
    arrow
    FNCE 2024
    Not Confirmed

    Daiichi Sankyo

    Ferric Carboxymaltose

    Main Therapeutic Indication : Hematology

    Currency : USD

    2020 Revenue in Millions : 410

    2019 Revenue in Millions : 456

    Growth (%) : -10

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Injectafer

    Ferric Carboxymaltose

    arrow
    FNCE 2024
    Not Confirmed

    Brand Name : Injectafer

    Japan
    arrow
    FNCE 2024
    Not Confirmed

    Daiichi Sankyo

    Ferric Carboxymaltose

    Main Therapeutic Indication : Hematology

    Currency : USD

    2021 Revenue in Millions : 672

    2020 Revenue in Millions : 407

    Growth (%) : 78

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Injectafer

    Ferric Carboxymaltose

    arrow
    FNCE 2024
    Not Confirmed

    Brand Name : Injectafer

    Japan
    arrow
    FNCE 2024
    Not Confirmed

    Daiichi Sankyo

    Ferric Carboxymaltose

    Main Therapeutic Indication : Hematology

    Currency : USD

    2022 Revenue in Millions : 404

    2021 Revenue in Millions : 672

    Growth (%) : -40

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Injectafer

    Ferric Carboxymaltose

    arrow
    FNCE 2024
    Not Confirmed

    Brand Name : Injectafer

    Japan
    arrow
    FNCE 2024
    Not Confirmed

    Daiichi Sankyo

    Ferric Carboxymaltose

    Main Therapeutic Indication : Hematology

    Currency : USD

    2023 Revenue in Millions : 340

    2022 Revenue in Millions : 404

    Growth (%) : -5

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Injectafer

    Ferric Carboxymaltose

    arrow
    FNCE 2024
    Not Confirmed

    Brand Name : Injectafer

    Japan
    arrow
    FNCE 2024
    Not Confirmed

    Daiichi Sankyo

    Ferric Carboxymaltose

    Main Therapeutic Indication : Blood Disorders

    Currency : USD

    2017 Revenue in Millions : 214

    2016 Revenue in Millions : 291

    Growth (%) : -27

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Injectafer

    Ferric Carboxymaltose

    arrow
    FNCE 2024
    Not Confirmed

    Brand Name : Injectafer

    Japan
    arrow
    FNCE 2024
    Not Confirmed

    Daiichi Sankyo

    Ferric Carboxymaltose

    Main Therapeutic Indication : Blood Disorders

    Currency : USD

    2018 Revenue in Millions : 387

    2017 Revenue in Millions : 200

    Growth (%) : 93%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Injectafer

    Ferric Carboxymaltose

    arrow
    FNCE 2024
    Not Confirmed

    Brand Name : Injectafer

    Japan
    arrow
    FNCE 2024
    Not Confirmed

    Daiichi Sankyo

    Ferric Carboxymaltose

    Main Therapeutic Indication : Hematology

    Currency : USD

    2019 Revenue in Millions : 452

    2018 Revenue in Millions : 400

    Growth (%) : 13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF